サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679151

骨盤臓器脱修復市場：世界の産業分析、規模、シェア、成長、動向、予測、2025年～2032年

Pelvic Organ Prolapse Repair Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 233 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
骨盤臓器脱修復市場：世界の産業分析、規模、シェア、成長、動向、予測、2025年～2032年
出版日: 2025年03月10日
発行: Persistence Market Research
ページ情報: 英文 233 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、骨盤臓器脱修復の世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・促進要因・課題などの重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。この調査レポートは、2025年から2032年までの骨盤臓器脱修復の世界市場の予測成長軌道を概説する独占データと統計を掲載しています。

主な洞察

  • 骨盤臓器脱修復の市場規模（2025年予測）：4億6,480万米ドル
  • 予測市場価値（2032年予測）：6億6,550万米ドル
  • 世界市場成長率（CAGR 2025～2032年）：4.6%

骨盤臓器脱修復市場 - 調査範囲

骨盤臓器脱修復術は、骨盤組織や筋肉の弱化や伸張によって下降する可能性のある膀胱、子宮、直腸などの骨盤臓器を適切な位置に戻すことを目的としています。この市場には、メッシュインプラント、膣ペッサリー、ロボット支援手術など、さまざまな外科的・非外科的修復オプションが含まれます。病院、専門クリニック、外来手術センターが、これらのソリューションの主要なエンドユーザーです。市場成長の原動力は、高齢化による骨盤臓器脱の有病率の増加、治療オプションに対する意識の高まり、回復が早く合併症が少ない低侵襲技術の進歩です。

市場促進要因：

骨盤臓器脱修復の世界市場は、特に女性の高齢化に伴う骨盤臓器脱の罹患率の上昇、治療オプションに対する意識の高まりなど、いくつかの主要な要因によって推進されています。さらに、ロボット支援手術や腹腔鏡手術などの低侵襲手術技術の進歩は、回復時間の短縮や合併症リスクの低減により、これらの治療法の採用を促進しています。また、快適性と利便性を重視する患者中心の治療傾向の高まりも、膣ペッサリーのような侵襲性の低い外来治療の需要を促進しています。

市場の抑制要因：

有望な成長が見込まれるものの、骨盤臓器脱修復市場は、感染症や臓器穿孔などのメッシュ関連合併症など、外科的介入に伴う合併症に関する課題に直面しています。さらに、高度な外科手術の高額な費用や地域によっては保険が適用されないため、患者の治療へのアクセスが制限される可能性があります。また、骨盤臓器脱とその治療を取り巻く文化的・社会的な偏見も、適時に医療介入を受けることを躊躇させる可能性があります。

市場機会：

骨盤臓器脱修復市場は、技術の進歩、人口動向、ヘルスケア提供モデルの進化によって大きな成長機会をもたらしています。より安全で効果的なメッシュインプラントの開発とロボット支援手術の利用拡大が、技術革新と患者の転帰改善の機会を生み出しています。さらに、膣ペッサリーの使用を含む外来治療に対する需要の高まりが、市場拡大の機会をもたらしています。特に閉経後の女性における骨盤臓器脱の有病率の増加に伴い、予防・治療ソリューションの市場が拡大しています。新たな機会を活かすには、戦略的パートナーシップ、研究開発への投資、より手頃な治療オプションの導入が不可欠です。

本レポートで扱う主な質問

  • 骨盤臓器脱修復市場の世界の成長を促進する主な要因は何か？
  • 異なるヘルスケア環境において、どの治療タイプや技術が骨盤臓器脱修復術の採用をリードしているか？
  • 技術の進歩は骨盤臓器脱修復市場の競合情勢をどのように変えているのか？
  • 骨盤臓器脱修復市場に貢献している主要企業はどこか、また、市場の関連性を維持するためにどのような戦略を採用しているか？
  • 世界の骨盤臓器脱修復市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 主な動向
  • マクロ経済要因
    • 世界のセクター別展望
    • 世界のGDP成長見通し
  • COVID-19の影響分析
  • 予測要因 - 関連性と影響

第3章 付加価値の洞察

  • 製品採用分析
  • 規制状況
  • バリューチェーン分析
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 世界の骨盤臓器脱修復市場の見通し

  • 主なハイライト
    • 市場規模と前年比成長率
    • 絶対的収益機会
  • 市場規模（百万米ドル）分析と予測
    • 過去の市場規模（百万米ドル）分析、2019～2024年
    • 現在の市場規模（百万米ドル）分析と予測、2025年～2032年
  • 世界の骨盤臓器脱修復市場の見通し：治療
    • イントロダクション/主な調査結果
    • 過去の市場規模（百万米ドル）分析、治療別、2019年～2024年
    • 現在の市場規模（百万米ドル）分析と予測、治療別、2025～2032年
      • 非外科的
        • ペッサリー
        • 骨盤底筋療法
      • 外科手術
        • 膣洗浄術
        • 膣縫合術
        • 仙骨膣固定術
        • 仙骨子宮固定術
        • 子宮仙骨靭帯または仙棘靭帯の固定
    • 市場の魅力分析：治療
  • 世界の骨盤臓器脱修復市場の展望：用途
    • イントロダクション/主な調査結果
    • 過去の市場規模（百万米ドル）の分析、用途別、2019年～2024年
    • 現在の市場規模（百万米ドル）分析と予測、用途別、2025～2032年
      • 膀胱瘤
      • 尿道瘤
      • 小腸瘤
      • 子宮脱
      • 後膣壁脱出（直腸下垂）
    • 市場の魅力分析：用途
  • 世界の骨盤臓器脱修復市場の見通し：エンドユーザー
    • イントロダクション/主な調査結果
    • 過去の市場規模（百万米ドル）の分析、エンドユーザー別、2019年～2024年
    • 現在の市場規模（百万米ドル）分析と予測、エンドユーザー別、2025～2032年
      • 病院
      • 専門クリニック
      • 女性介護施設
    • 市場の魅力分析：エンドユーザー

第5章 世界の骨盤臓器脱修復市場の展望：地域

  • 主なハイライト
  • 過去の市場規模（百万米ドル）の分析、地域別、2019年～2024年
  • 現在の市場規模（百万米ドル）分析と予測、地域別、2025～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第6章 北米の骨盤臓器脱修復市場の見通し

第7章 欧州の骨盤臓器脱修復市場の見通し

第8章 東アジアの骨盤臓器脱修復市場の見通し

第9章 南アジアおよびオセアニアの骨盤臓器脱修復市場の見通し

第10章 ラテンアメリカ骨盤臓器脱修復市場の見通し

第11章 中東およびアフリカの骨盤臓器脱修復市場の見通し

第12章 競合情勢

  • 市場シェア分析、2024年
  • 市場構造
    • 市場別の競合激化マップ
    • 競合ダッシュボード
  • 企業プロファイル（詳細 - 概要、財務、戦略、最近の動向）
    • Johnson &Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation（American Medical Systems Inc.）
    • pfm medical ag
    • Betatech Medical
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • CooperSurgical, Inc.
    • DIMA SL
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.
    • For.me.sa.
    • Bioteque America Inc.
    • Bliss GVS Pharma
    • Panpac Medical Corporation
    • Personal Medical Corporation
    • Dr. Arabin GmbH &Co.
    • Kangge Medical
    • Integra Lifesciences
    • Wallach Surgical Devices
    • Medesign

第13章 付録

  • 調査手法
  • 調査の前提
  • 頭字語と略語
目次
Product Code: PMRREP31735

Persistence Market Research has recently released a comprehensive report on the worldwide market for pelvic organ prolapse repair. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global pelvic organ prolapse repair market from 2025 to 2032.

Key Insights:

  • Pelvic Organ Prolapse Repair Market Size (2025E): US$ 464.8 Mn
  • Projected Market Value (2032F): US$ 665.5 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Pelvic Organ Prolapse Repair Market - Report Scope:

Pelvic organ prolapse repair procedures aim to restore the proper positioning of pelvic organs, such as the bladder, uterus, and rectum, that may descend due to weakening or stretching of pelvic tissues and muscles. The market includes various surgical and non-surgical repair options, including mesh implants, vaginal pessaries, and robotic-assisted surgeries. Hospitals, specialized clinics, and ambulatory surgical centers are key end-users of these solutions. Market growth is driven by the increasing prevalence of pelvic organ prolapse due to an aging population, rising awareness of treatment options, and advancements in minimally invasive techniques, which offer faster recovery times and fewer complications.

Market Growth Drivers:

The global pelvic organ prolapse repair market is propelled by several key factors, including the rising incidence of pelvic organ prolapse, especially among aging women, and increasing awareness of treatment options. Additionally, advancements in minimally invasive surgical technologies, such as robotic-assisted surgery and laparoscopic procedures, are enhancing the adoption of these treatments due to the shorter recovery times and reduced risk of complications. The growing trend of patient-centered care, which emphasizes comfort and convenience, is also driving demand for less invasive, outpatient treatments such as vaginal pessaries.

Market Restraints:

Despite promising growth prospects, the pelvic organ prolapse repair market faces challenges related to complications associated with surgical interventions, including mesh-related complications such as infections and organ perforation. Furthermore, the high cost of advanced surgical procedures and the lack of insurance coverage in certain regions may limit patient access to treatment. Cultural and social stigmas surrounding pelvic organ prolapse and its treatment may also deter individuals from seeking timely medical intervention.

Market Opportunities:

The pelvic organ prolapse repair market presents significant growth opportunities driven by technological advancements, demographic trends, and evolving healthcare delivery models. The development of safer, more effective mesh implants and the increasing use of robotic-assisted surgery create opportunities for innovation and improved patient outcomes. Additionally, the growing demand for outpatient treatments, including the use of vaginal pessaries, presents opportunities for market expansion. With the increasing prevalence of pelvic organ prolapse, especially in postmenopausal women, there is a growing market for preventive and treatment solutions. Strategic partnerships, investment in research and development, and the introduction of more affordable treatment options will be essential to capitalize on emerging opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the pelvic organ prolapse repair market globally?
  • Which treatment types and technologies are leading the adoption of pelvic organ prolapse repair procedures in different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the pelvic organ prolapse repair market?
  • Who are the key players contributing to the pelvic organ prolapse repair market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global pelvic organ prolapse repair market?

Competitive Intelligence and Business Strategy:

Leading players in the global pelvic organ prolapse repair market, including Johnson & Johnson, Medtronic, and Boston Scientific, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced surgical devices, including mesh implants, robotic-assisted surgery systems, and non-invasive treatment solutions. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, an emphasis on clinical research, evidence-based practices, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving pelvic organ prolapse repair landscape.

Key Companies Profiled:

  • Johnson & Johnson
  • Medtronic
  • Boston Scientific
  • Intuitive Surgical, Inc.
  • Coloplast Corporation
  • B. Braun Melsungen AG
  • Cook Medical
  • Integra LifeSciences
  • ConMed Corporation
  • Abbott Laboratories

Pelvic Organ Prolapse Repair Market Segmentation

By Treatment

  • Non-surgical
  • Surgical

By Application

  • Cystocele
  • Urethrocele
  • Enterocele
  • Uterine Prolapse
  • Posterior Vaginal Wall Prolapse

By End User

  • Hospitals
  • Specialized Clinics
  • Female Care Facilities

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Global Pelvic Organ Prolapse Repair Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Pelvic Organ Prolapse Repair Market Outlook: Treatment
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Treatment, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
      • 4.3.3.1. Non-surgical
        • 4.3.3.1.1. Pessary
        • 4.3.3.1.2. Pelvic Floor Muscle Therapy
      • 4.3.3.2. Surgical
        • 4.3.3.2.1. Colpocleisis
        • 4.3.3.2.2. Colporrhaphy
        • 4.3.3.2.3. Sacrocolpopexy
        • 4.3.3.2.4. Sacrohysteropexy
        • 4.3.3.2.5. Uterosacral or Sacrospinous Ligament Fixation
    • 4.3.4. Market Attractiveness Analysis: Treatment
  • 4.4. Global Pelvic Organ Prolapse Repair Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn), By Application, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Cystocele
      • 4.4.3.2. Urethrocele
      • 4.4.3.3. Enterocele
      • 4.4.3.4. Uterine Prolapse
      • 4.4.3.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Pelvic Organ Prolapse Repair Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Specialized Clinics
      • 4.5.3.3. Female Care Facilities
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Pelvic Organ Prolapse Repair Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Pelvic Organ Prolapse Repair Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Treatment
    • 6.2.3. By Application
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 6.4.1. Non-surgical
      • 6.4.1.1. Pessary
      • 6.4.1.2. Pelvic Floor Muscle Therapy
    • 6.4.2. Surgical
      • 6.4.2.1. Colpocleisis
      • 6.4.2.2. Colporrhaphy
      • 6.4.2.3. Sacrocolpopexy
      • 6.4.2.4. Sacrohysteropexy
      • 6.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Cystocele
    • 6.5.2. Urethrocele
    • 6.5.3. Enterocele
    • 6.5.4. Uterine Prolapse
    • 6.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Specialized Clinics
    • 6.6.3. Female Care Facilities
  • 6.7. Market Attractiveness Analysis

7. Europe Pelvic Organ Prolapse Repair Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Treatment
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 7.4.1. Non-surgical
      • 7.4.1.1. Pessary
      • 7.4.1.2. Pelvic Floor Muscle Therapy
    • 7.4.2. Surgical
      • 7.4.2.1. Colpocleisis
      • 7.4.2.2. Colporrhaphy
      • 7.4.2.3. Sacrocolpopexy
      • 7.4.2.4. Sacrohysteropexy
      • 7.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Cystocele
    • 7.5.2. Urethrocele
    • 7.5.3. Enterocele
    • 7.5.4. Uterine Prolapse
    • 7.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialized Clinics
    • 7.6.3. Female Care Facilities
  • 7.7. Market Attractiveness Analysis

8. East Asia Pelvic Organ Prolapse Repair Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Treatment
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 8.4.1. Non-surgical
      • 8.4.1.1. Pessary
      • 8.4.1.2. Pelvic Floor Muscle Therapy
    • 8.4.2. Surgical
      • 8.4.2.1. Colpocleisis
      • 8.4.2.2. Colporrhaphy
      • 8.4.2.3. Sacrocolpopexy
      • 8.4.2.4. Sacrohysteropexy
      • 8.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Cystocele
    • 8.5.2. Urethrocele
    • 8.5.3. Enterocele
    • 8.5.4. Uterine Prolapse
    • 8.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialized Clinics
    • 8.6.3. Female Care Facilities
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Pelvic Organ Prolapse Repair Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Treatment
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 9.4.1. Non-surgical
      • 9.4.1.1. Pessary
      • 9.4.1.2. Pelvic Floor Muscle Therapy
    • 9.4.2. Surgical
      • 9.4.2.1. Colpocleisis
      • 9.4.2.2. Colporrhaphy
      • 9.4.2.3. Sacrocolpopexy
      • 9.4.2.4. Sacrohysteropexy
      • 9.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Cystocele
    • 9.5.2. Urethrocele
    • 9.5.3. Enterocele
    • 9.5.4. Uterine Prolapse
    • 9.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialized Clinics
    • 9.6.3. Female Care Facilities
  • 9.7. Market Attractiveness Analysis

10. Latin America Pelvic Organ Prolapse Repair Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Treatment
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 10.4.1. Non-surgical
      • 10.4.1.1. Pessary
      • 10.4.1.2. Pelvic Floor Muscle Therapy
    • 10.4.2. Surgical
      • 10.4.2.1. Colpocleisis
      • 10.4.2.2. Colporrhaphy
      • 10.4.2.3. Sacrocolpopexy
      • 10.4.2.4. Sacrohysteropexy
      • 10.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Cystocele
    • 10.5.2. Urethrocele
    • 10.5.3. Enterocele
    • 10.5.4. Uterine Prolapse
    • 10.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialized Clinics
    • 10.6.3. Female Care Facilities
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Treatment
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2025-2032
    • 11.4.1. Non-surgical
      • 11.4.1.1. Pessary
      • 11.4.1.2. Pelvic Floor Muscle Therapy
    • 11.4.2. Surgical
      • 11.4.2.1. Colpocleisis
      • 11.4.2.2. Colporrhaphy
      • 11.4.2.3. Sacrocolpopexy
      • 11.4.2.4. Sacrohysteropexy
      • 11.4.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Cystocele
    • 11.5.2. Urethrocele
    • 11.5.3. Enterocele
    • 11.5.4. Uterine Prolapse
    • 11.5.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialized Clinics
    • 11.6.3. Female Care Facilities
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Johnson & Johnson Services, Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Coloplast A/S
    • 12.3.3. Dipromed Srl
    • 12.3.4. Boston Scientific Corporation (American Medical Systems Inc.)
    • 12.3.5. pfm medical ag
    • 12.3.6. Betatech Medical
    • 12.3.7. Promedon Group
    • 12.3.8. Caldera Medical
    • 12.3.9. Cook Medical
    • 12.3.10. Medgyn Products, Inc.
    • 12.3.11. CooperSurgical, Inc.
    • 12.3.12. DIMA S.L.
    • 12.3.13. Digitimer Ltd.
    • 12.3.14. Bray Group Ltd.
    • 12.3.15. Medesign Ingenieur-Consulting GmbH
    • 12.3.16. Panpac Medical Corp.
    • 12.3.17. For.me.sa.
    • 12.3.18. Bioteque America Inc.
    • 12.3.19. Bliss GVS Pharma
    • 12.3.20. Panpac Medical Corporation
    • 12.3.21. Personal Medical Corporation
    • 12.3.22. Dr. Arabin GmbH & Co.
    • 12.3.23. Kangge Medical
    • 12.3.24. Integra Lifesciences
    • 12.3.25. Wallach Surgical Devices
    • 12.3.26. Medesign

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations